BriefsAstraZeneca licensed LeadScope software and databases
COLUMBUS, Ohio, Aug. 21 /PRNewswire/ LeadScope(R) Inc. today announced that AstraZeneca (NYSE: AZN) has licensed the LeadScope Enterprise(TM) software and ToxScope(TM) databases to assist in evaluating high throughput screening (HTS) campaigns, correlating biological information with structural features of chemical libraries to create a data mining system that incorporates advanced searching and browsing capabilities. LeadScope Enterprise is a new server-based decision-support software solution that promises seamless access to corporate data, along with chemically based data-mining and visualization capabilities. The ToxScope databases encompass acute toxicity, hepatotoxicity, mutagenicity and carcinogenicity. ToxScope enables the user to make side-by- side comparisons of efficacy screening and toxicity information, use structural alerts from any source, explore chemical space of any data set and manage complex in-house data. "Getting the most out of the data generated from the huge investment pharmaceutical companies have made in high throughput screening and combinatorial chemistry is key to accelerating drug discovery," commented Pamela Springer, Vice President of Sales for LeadScope Inc. "We are thrilled that AstraZeneca has selected the LeadScope Enterprise product to data mine their corporate chemical and biological screening databases." "We have found LeadScope Enterprise to be very useful in rapidly identifying correlations between chemical structural features and biological activity, thereby improving the quality of research decisions in the early HTS evaluation phase," commented Christer Westerlund, for AstraZeneca, Medicinal Chemistry Molndal, Sweden. AstraZeneca is a major international healthcare business engaged in the research, development, manufacture and marketing of ethical (prescription) pharmaceuticals and the supply of healthcare services. It is one of the top five pharmaceutical companies in the world with healthcare sales of $15.8 billion and leading positions in sales of gastrointestinal, oncology, anesthesia (including pain management), cardiovascular, central nervous system (CNS) and respiratory products. Since 1997, LeadScope Inc. has focused on creating chemically intelligent decision-support software that meets the changing needs of life scientists. The LeadScope product line includes LeadScope Enterprise, server-based decision-support software; Personal(TM) LeadScope, the desktop version of Enterprise; ToxScope, a series of toxicity databases; and soon-to-be released GeneScope(TM), a gene expression analysis and chemical genomics system. The expertise of LeadScope ( http://www.leadscope.com ) includes an in- depth knowledge of advanced informatics technology and the services necessary to help organizations effectively extract and visualize the valuable knowledge contained in research data. LeadScope Inc. is dedicated to working with their customers to shorten drug development time and dramatically increase the quality of research decisions.
Copyright © 2001 KDnuggets. Subscribe to KDnuggets News!